Biofourmis
AI platform for remote patient monitoring
- Type
- Company / Project
- Vertical / Group
- Healthcare
- AI Relation
- Core AI
- Public Funding
- $463.6M
- Valuation
- $1.3B
- Status
- Active
- Website
- biofourmis.com
Positioning
Biofourmis is tracked as a company or project in the Healthcare vertical of Singapore's AI startup ecosystem. Its public positioning is: AI platform for remote patient monitoring.
Capital And Market Signals
- Unicorn / listed-scale signal: raised $463.6M, valuation $1.3B, status Active.
- Public funding signal: $463.6M.
- Current tag: Unicorn.
AI Relation
The main product or value proposition is directly built on AI, ML, computer vision, LLMs, robotics intelligence, or closely related model-driven capabilities. It can be treated as a strict AI company or AI project.
Why It Matters
Biofourmis is a concrete signal for whether Singapore can turn policy, talent, and research inputs into commercially useful AI companies in the Healthcare vertical.
Signals To Track
- Whether the product moves from a single AI feature toward a repeatable platform or industry workflow.
- Whether customers are mainly local, regional across Southeast Asia, or global.
- Whether signals such as funding, revenue, open-source traction, or regulatory clearance keep strengthening.
Related Entities
Qritive
AI digital pathology diagnostics
Engine Bio
CRISPR + ML diagnostics platform
Bot MD
AI assistant for clinicians
Nanyang Biologics
AI drug discovery
ADVANCE.AI
AI-driven digital identity verification and risk management
Aspire
SME finance platform (AI-enabled)
Data Note
This entity profile was organized and its AI-relation label was checked on 2026-05-04. Aggregate ecosystem statistics such as startup count, funding share, and total VC raised use the public baseline as of 2026-02-17. Funding, valuation, and exit amounts follow public reporting or public datasets; different databases may use different definitions for the same company.